The Hongkong and Shanghai Hotels (45) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
18 Mar, 2026Executive summary
Returned to profitability in 2025, with HK$320m profit attributable to shareholders, reversing a HK$943m loss in 2024, and underlying profit of HK$105m, driven by disciplined execution, strong brand positioning, and robust hotel and commercial property performance.
Completed a comprehensive strategic review, resulting in Vision 2035: Perform and Transform, focusing on operational excellence, selective growth, and value creation under new leadership.
Financial highlights
Revenue from operations (excluding residential sales) increased by 11% year-over-year to HK$7,583m, with operating EBITDA up 43% to HK$1,723m, reflecting strong flow-through from revenue growth and cost management.
Underlying profit reached HK$105m, a turnaround from an underlying loss of HK$176m last year.
Net cash from operations increased by 69% to HK$839m; net external debt to total assets stable at 23%.
Major financing included a debut JPY16bn Samurai Bond and GBP425m refinanced Green Club Loan.
Total consolidated revenue was HK$7,978m, down 22% due to fewer Peninsula London Residences sales.
Outlook and guidance
Management remains cautiously optimistic for 2026, expecting continued recovery in luxury travel demand, steady progression, and a focus on profitable growth, digital transformation, sustainability, and workforce stability.
Peninsula Tokyo and U.S. portfolio expected to remain top performers; London and Istanbul ramping up brand presence.
Vision 2035 aims for balanced, intentional growth, operational excellence, and expansion into resorts and branded residences.
Latest events from The Hongkong and Shanghai Hotels
- Revenue surged on London sales, but higher costs and revaluation losses resulted in a net loss.45
H1 20242 Feb 2026 - Revenue up 26–27% to HK$10.3B–HK$10.99B, but net loss of HK$943M; 2025 outlook optimistic.45
H2 20247 Jan 2026 - Strong revenue and EBITDA growth, narrowed losses, and a positive outlook despite risks.45
H1 20256 Jan 2026